Vitamin D in Mild to Moderate COVID-۱۹: A Retrospective Cross-Sectional Study

  • سال انتشار: 1402
  • محل انتشار: مجله علوم دارویی و شیمی، دوره: 6، شماره: 1
  • کد COI اختصاصی: JR_JMCH-6-1_007
  • زبان مقاله: انگلیسی
  • تعداد مشاهده: 135
دانلود فایل این مقاله

نویسندگان

Reza Sahraeai

Research Center for Non.Communicable Diseases, Jahrom University of Medical Sciences, Jahrom, Iran

Farhang Hooshmand

Research Center for Non.Communicable Diseases, Jahrom University of Medical Sciences, Jahrom, Iran

Mojtaba Ghaedi

Research Center for Non.Communicable Diseases, Jahrom University of Medical Sciences, Jahrom, Iran

Shahram Shafa

Research Center for Non.Communicable Diseases, Jahrom University of Medical Sciences, Jahrom, Iran

Fatemeh Eftekharian

Research Center for Non.Communicable Diseases, Jahrom University of Medical Sciences, Jahrom, Iran

Samira Farrokhi

Research Center for Non.Communicable Diseases, Jahrom University of Medical Sciences, Jahrom, Iran

چکیده

Background: Vitamin D linkage with COVID-۱۹ is investigated in many studies, but there is still no single summation. Thus, this study aimed to evaluate the relationship between Vitamin D levels and clinical characteristics of COVID-۱۹.Methods: This was a retrospective cross-sectional study on floor admitted COVID-۱۹ patients in the Jahrom province of Iran in ۲۰۲۰. The patients in this study were divided into different groups based on vitamin D status after the definitive diagnosis of COVID-۱۹. Demographic and clinical characteristics of COVID-۱۹ patients were analyzed based on the COVID-۱۹ status. Results: Vitamin D levels were normal for almost half of the patients (۵۱.۷%) and the rest were insufficient (۲۵.۹%) or deficient (۲۲.۴%). Serum vitamin D levels did not correlate with vital sign data and venous blood gas results (P> ۰.۰۵). Vitamin D status was not different among patients with different symptoms of COVID-۱۹ (P> ۰.۰۵).Conclusion: Our results revealed that vitamin D levels is not correlated to clinical characteristics in COVID-۱۹ patients. In addition, well-designed studies with a good sample size are required to draw conclusions.

کلیدواژه ها

SARS-CoV-۲, Vitamin D, COVID-۱۹, clinical outcomes

اطلاعات بیشتر در مورد COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.